Business

The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.

The company will use the funds to scale its reach within the U.S. and to expand access to its offerings globally.

The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.

When implementing AI-powered assistants and ambient technologies, it is essential to know if what you are buying is an actual assistant and if it has features beyond just clinical documentation, says Punit Soni, founder and CEO of Suki.

The company is adding 4,200 clinics to its provider network and enabling cost-sharing as well as direct claims payment to providers and clinicians.

The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac conditions and new distribution channels.

A Silicon Valley Bank report reveals that healthcare sectors experienced strong growth in AI deal activity, especially in healthtech and biopharma.

If organizations are more transparent with clinicians and patients about AI adoption and deployment, stakeholders would feel more secure with it, says Nicole Ramage, senior market insights manager at HIMSS.

The company, which uses AI to help companies manage value-based care contracts, will use the funds to grow its team and scale its platform.

The funding comes a year after the company secured $70 million in a Series B funding round.